Nidhish Chandra Mathilakath,Puneet Kumar,Vishal Anand
Nidhish Chandra Mathilakath
Ginsenoside Compound K Inhibits Wnt/β-Catenin Signaling and Anti-Angiogenesis, Alleviating Joint Injury in Rats With Adjuvant Arthritis [0.03%]
绞股蓝皂苷化合物K通过抑制Wnt/β-catenin信号通路及抗血管生成缓解佐剂性关节炎大鼠的关节损伤
Xiujin Xu,Xuran Zeng,Yanqiu Zhang et al.
Xiujin Xu et al.
Objective: To explore the effect and mechanism of GCK on synovial angiogenesis in AA rats. Methods: After establishing the rat model of...
Can HALP Score Predict the Prognosis of Patients With Giant Cell Arteritis and Polymyalgia Rheumatica? [0.03%]
HALP评分能预测巨细胞动脉炎和多肌炎患者的预后吗？
Firdevs Ulutaş,Hande Şenol,Murat Yiğit et al.
Firdevs Ulutaş et al.
Objective: The HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) score has recently gained frequent use in oncology practice as a predictive marker of survival. Giant Cell Arteritis and Polymyalgia Rheumatica are commo...
Case Report: Rituximab Treatment for Refractory Skin Involvement in Anti-TIF1γ Dermatomyositis Without Associated Malignancy [0.03%]
个例报告：抗TIF1γ皮肌炎相关皮肤受累的利妥昔单抗治疗（无相关恶性肿瘤）
Elif Dincses-Nas
Elif Dincses-Nas
Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid Arthritis [0.03%]
肥胖通过肝功能损害阻碍日本类风湿关节炎患者的最佳甲氨蝶呤剂量 escalation和疗效
Soshi Takahashi,Miho Shibata,Miho Takahashi et al.
Soshi Takahashi et al.
Aim: To evaluate the impact of overweight on methotrexate (MTX) efficacy and liver function in Japanese patients with rheumatoid arthritis (RA), and to explore whether liver dysfunction contributes to MTX dose limitation ...
Fruit Consumption and Rheumatoid Arthritis: A Two-Sample Mendelian Randomization Study [0.03%]
基于孟德尔随机化研究的水果摄入与类风湿性关节炎关系分析
Zeyue Chen,Xuanli Zhao,Ying Chen et al.
Zeyue Chen et al.
Targeting IL-1 in Autoinflammatory Syndromes: Lessons From Canakinumab and VEXAS Syndrome [0.03%]
IL-1在自身炎症综合征中的靶向治疗：Canakinumab和VEXAS综合征带来的启示
Tang-Kai Cheng,Hung-Ke Lin,Ping Zeng
Tang-Kai Cheng
Predictive Factors for Renal Outcome During Remission Induction Treatment Period in Lupus Nephritis [0.03%]
系统性红斑狼疮肾炎诱导治疗期肾脏结局的预测因素分析
Kazuro Kamada,Michihito Kono,Shuhei Takeyama et al.
Kazuro Kamada et al.
Objectives: Patients with refractory lupus nephritis (LN) may benefit from the addition of anti-lupus drugs to standard remission induction therapy; however, which patients require additional treatment remains unclear. Th...
Observational Study
International journal of rheumatic diseases. 2025 Nov;28(11):e70470. DOI:10.1111/1756-185x.70470 2025
High Frequency of Muscle Activity Relapses in Anti-Jo-1 Antisynthetase Syndrome [0.03%]
抗Jo-1合成酶综合征患者肌活检的高频电生理检查结果
Kaioan Choma,Caio Gabriel Jeronymo Lima Brasileiro,Fernando Henrique Carlos De Souza et al.
Kaioan Choma et al.